What is the recommended dose of heparin (anticoagulant) in a peritoneal dialysis bag?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heparin Dosing in Peritoneal Dialysis

For peritoneal dialysis, add 500 units of heparin per liter of dialysate to prevent intraperitoneal fibrin formation without causing systemic anticoagulation. 1

Recommended Dosing Protocol

Standard Concentration

  • Add 500 units/L (0.5 units/mL) of unfractionated heparin to each peritoneal dialysis bag 1
  • This concentration effectively prevents fibrin precipitation in the dialysate while maintaining negligible systemic absorption 1
  • Alternative dosing of 2.5-5 units/mL has been studied, though 500 units/L represents the most validated approach 2

Mechanism and Rationale

  • The low antithrombin III (AT-III) concentration in dialysate (approximately 0.44 mg/dL, only 1.5% of plasma levels) is sufficient to inhibit thrombin activity when accelerated by heparin 1, 2
  • Intraperitoneal heparin dramatically reduces fibrinopeptide A (a marker of fibrin formation) in dialysate from 155.8 ng/mL to 8.5 ng/mL 1
  • Plasma fibrinopeptide A levels also decrease from 63.2 ng/mL to 4.9 ng/mL, indicating reduced systemic coagulation activation 1

Pharmacokinetics and Safety

Systemic Absorption

  • No detectable heparin activity appears in plasma even after 52 hours of continuous intraperitoneal administration at 500 units/L 1
  • The half-life of heparin activity in dialysate is only 0.5-2 hours, with activity dropping to 0.5-1.4 units/mL by 6 hours 2
  • Whole blood clotting time remains unaffected due to minimal transfer to plasma 2

Clinical Indications for Use

  • Most beneficial at the initiation of CAPD when fibrin formation risk is highest 2
  • Essential during peritonitis episodes when intraperitoneal AT-III levels are relatively increased 2
  • Prevents catheter dysfunction from fibrin sheath formation 3

Important Clinical Considerations

When to Use Heparin in PD Bags

  • Routine use is not necessary for all exchanges in stable patients 2
  • Reserve for situations with increased fibrin formation risk: new catheter placement, peritonitis, bloody dialysate, or catheter malfunction 2

Monitoring

  • No aPTT monitoring required due to lack of systemic anticoagulation 1
  • Visual inspection of dialysate for fibrin strands or cloudiness is sufficient 1

Common Pitfalls to Avoid

  • Do not use hemodialysis heparin dosing protocols (which require 5000 unit bolus plus 1500 units/hour infusion) for peritoneal dialysis 4
  • Avoid confusion between catheter flush solutions (which use 500-5000 units for central venous catheters) and intraperitoneal dialysate dosing 3
  • Higher concentrations (>5 units/mL) provide no additional benefit and waste medication 2

References

Research

Effect of intraperitoneal administration of heparin to patients on continuous ambulatory peritoneal dialysis (CAPD).

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Objective assessment of heparin requirements for hemodialysis in humans.

The Journal of laboratory and clinical medicine, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.